Intra-Cellular Therapies Total Current Assets 2013-2024 | ITCI

Intra-Cellular Therapies total current assets for the quarter ending September 30, 2024 were $1.272B, a 81.05% increase year-over-year.

  • Intra-Cellular Therapies total current assets for 2023 were $0.668B, a 9.51% decline from 2022.
  • Intra-Cellular Therapies total current assets for 2022 were $0.738B, a 57.93% increase from 2021.
  • Intra-Cellular Therapies total current assets for 2021 were $0.467B, a 32.37% decline from 2020.

Intra-Cellular Therapies Total Current Assets 2013-2024 | ITCI

  • Intra-Cellular Therapies total current assets for 2023 were $0.668B, a 9.51% decline from 2022.
  • Intra-Cellular Therapies total current assets for 2022 were $0.738B, a 57.93% increase from 2021.
  • Intra-Cellular Therapies total current assets for 2021 were $0.467B, a 32.37% decline from 2020.